
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
#189Wednesday · 25 min
#188August 19 · 30 minThe ASRS ReST Commitee
#187August 12 · 14 minThe Therapeutic Pipeline for Geographic Atrophy in AMD
#186August 4 · 19 minHand Held Office Based ERG for Evaluating Diabetic Retinopathy
#185July 30 · 11 min4 Year Outcomes of Faricimab Therapy of Neovascular AMD
#184July 21 · 11 min5 Year Results of Pegacetacoplan Treatment of Geographic Atrophy
#183July 15 · 16 minPolychoroidal Vasculopathy (PCV)
#182July 7 · 19 minAREDS Vitamins and Geographic Atrophy
#181June 16 · 20 minIntravitreal Gene Therapy for Neovascular AMD with 4D-150
#180June 8 · 22 minHome OCT in Management of Neovascular AMD
#179June 4 · 13 minFaricimab in the Treatment of DME: Long Term 'Results
#178May 28 · 17 minXelafaslatide for the Treatment of Geographic Atrophy
#177May 19 · 12 minInhibition of IL-6 in the Treatment of Retinal Disease
#176May 12 · 14 minAflibercept 8mg for Retinal Vein Occlusion
#175April 29 · 7 minElamipretide in the Treatment of Geographic Atrophy
#174April 22 · 9 minLong Term Followup of Intravitreal Gene Therapy for Neovascular AMD
#173April 14 · 28 minThe Port Delivery Stem for Treatment of Neovascular AMD
#172April 7 · 20 minKamuvudine 8 in the Treatment of Geographic Atrophy
#171March 31 · 14 minTreatment of Proliferative Diabetic Retinopathy After Protocol S
#170March 24 · 16 minEncapsulated Cell Therapy for MacTel2